Laetitia Cohen Tannoudji

Laetitia Cohen Tannoudji has over 18 years of experience in the pharmaceutical industry. Laetitia began their career in 2003 as a Doctorant at CNRS. In 2007, they moved to LFB as Responsable du laboratoire Developpement de Formulation and Ingénieur de recherche. In 2014, they joined Innate Pharma as Director CMC Process & Formulation, where they were responsible for managing teams responsible for production & purification of antibodies and proteins for research and development use, technical oversight of CMOs in charge of process development and GMP activities, and leading developability and early stage CMC development for the selection of Antibody candidate. Laetitia also managed the team in charge of formulation activities and wrote & reviewed IMPD/IND dossier (Module 3 Quality). In 2021, they became Director, CMC Operations at Emergence Therapeutics.

Laetitia Cohen Tannoudji completed their Doctorat in Matière condensée from UPMC Paris VI in 2006. Prior to that, they obtained their DEA in the same field from the same university in 2003. Laetitia also obtained an Ingénieur degree in Physico chimie from ESPCI in 2003.